Kymera Therapeutics (KYMR) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.79
-0.73
-0.66
-0.6

Details

Expected EPS
-0.71
Actual EPS
-0.67
Surprise EPS
0.04
Surprise Percent
+5.63%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.67 per share for Q2 2023.

0 Comments

Share your thoughts